Welcome to the Integrated System for Pfizer Investigator Initiated Research (INSPIIRE)

  Login
Captcha

For security, please type the letters above:
  New Users
 
Announcements
Please email us at: CTD@pfizer.com for assistance with the CLINICAL TRIAL DATA REQUESTS
Please email us at: IIR@pfizer.com for assistance with INVESTIGATOR INITIATED RESEARCH or COMPOUND TRANSFER REQUESTS
ATTENTION HIV/Maraviroc Requests: Please contact viiv.csgoperations@viivhealthcare.com
Site is NOT compatible with Safari. Please use IE or Chrome when using this site.
If you applying for grant from Meridian Medical Technologies, please include “MERIDIAN” at the start of your study title so that we can ensure your proposal is routed internally as quickly as possible.
If you are interested in submitting an avelumab proposal that includes another Merck Serono product, please submit directly via the Merck Serono portal.
On September 27, 2016, Pfizer completed acquisition of Medivation. In order to allow time for full integration of processes and requirements, Pfizer will not be accepting new IIR/ISR requests for legacy Medivation products until April 1, 2017.
Due to updated privacy law, Russian Investigators must first submit their application to a Pfizer local country office colleague before submitting on the portal. If you do not have a local country contact, email IIR@Pfizer.com